Literature DB >> 20933113

Mechanism of action of emergency contraception.

Kristina Gemzell-Danielsson1.   

Abstract

A major barrier to the widespread acceptability and use of emergency contraception (EC) are concerns regarding the mechanisms of action of EC methods. Today, levonorgestrel (LNG) in a single dose of 1.5 mg taken within 120 h of an unprotected intercourse is the most widely used EC method worldwide. It has been demonstrated that LNG-EC acts through an effect on follicular development to delay or inhibit ovulation but has no effect once luteinizing hormone has started to increase. Thereafter, LNG-EC cannot prevent ovulation and it does not prevent fertilization or affect the human fallopian tube. LNG-EC has no effect on endometrial development or function. In an in vitro model, it was demonstrated that LNG did not interfere with blastocyst function or implantation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20933113     DOI: 10.1016/j.contraception.2010.05.004

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  13 in total

Review 1.  Ulipristal acetate: a review of its use in emergency contraception.

Authors:  Kate McKeage; Jamie D Croxtall
Journal:  Drugs       Date:  2011-05-07       Impact factor: 9.546

2.  Embracing post-fertilisation methods of family planning: a call to action.

Authors:  Elizabeth G Raymond; Francine Coeytaux; Kristina Gemzell-Danielsson; Kirsten Moore; James Trussell; Beverly Winikoff
Journal:  J Fam Plann Reprod Health Care       Date:  2013-10

Review 3.  Does levonorgestrel emergency contraceptive have a post-fertilization effect? A review of its mechanism of action.

Authors:  Rebecca Peck; Walter Rella; Julio Tudela; Justo Aznar; Bruno Mozzanega
Journal:  Linacre Q       Date:  2016-02

4.  Efficacy and safety of a levonorgestrel enteric-coated tablet as an over-the-counter drug for emergency contraception: a Phase IV clinical trial.

Authors:  Q-J Chen; W-P Xiang; D-K Zhang; R-P Wang; Y-F Luo; J-Z Kang; L-N Cheng
Journal:  Hum Reprod       Date:  2011-06-13       Impact factor: 6.918

5.  Pioneering studies of the "morning-after" pill.

Authors:  Mary J Kunjappu
Journal:  Yale J Biol Med       Date:  2011-06

6.  Immunopharmacology of ulipristal as an emergency contraceptive.

Authors:  Ralph P Miech
Journal:  Int J Womens Health       Date:  2011-11-22

7.  Association between levonorgestrel emergency contraception and the risk of ectopic pregnancy: a multicenter case-control study.

Authors:  Jian Zhang; Cheng Li; Wei-Hong Zhao; Xiaowei Xi; Shu-Jun Cao; Hua Ping; Guo-Juan Qin; Linan Cheng; He-Feng Huang
Journal:  Sci Rep       Date:  2015-02-12       Impact factor: 4.379

8.  Risk factors and clinical features of ovarian pregnancy: a case-control study.

Authors:  Qian Zhu; Cheng Li; Wei-Hong Zhao; Jiang-Jing Yuan; Ming-Xing Yan; Guo-Juan Qin; Jian Zhang
Journal:  BMJ Open       Date:  2014-12-03       Impact factor: 2.692

9.  Expressions of candidate molecules in the human fallopian tube and chorionic villi of tubal pregnancy exposed to levonorgestrel emergency contraception.

Authors:  Changxiao Huang; Mei Zhang; Chunxia Meng; Wei Shi; Lulu Sun; Jian Zhang
Journal:  Reprod Biol Endocrinol       Date:  2013-05-20       Impact factor: 5.211

10.  A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.

Authors:  Mario P R Festin; Luis Bahamondes; Thi My Huong Nguyen; Ndema Habib; Manopchai Thamkhantho; Kuldip Singh; Arundhati Gosavi; Gyorgy Bartfai; Tamas Bito; M Valeria Bahamondes; Nathalie Kapp
Journal:  Hum Reprod       Date:  2016-01-31       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.